Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression is a research paper published in Journal of Clinical Investigation (2018). On theSindex it has a DataRank of 0.961. It has been cited 605 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.961
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →the National Institutes of Health grants
Grant: CA123088
the National Institutes of Health grants
Grant: CA099985
the National Institutes of Health grants
Grant: CA156685
the National Institutes of Health grants
Grant: CA171306
the National Institutes of Health grants
Grant: CA190176
the National Institutes of Health grants
Grant: CA193136
the National Institutes of Health grants
Grant: CA211016
the National Institutes of Health grants
Grant: 5P30CA46592
MedImmune
Grant: the sponsored research grant
NCI NIH HHS
Grant: R01 CA193136
NCI NIH HHS
Grant: R01 CA099985
NCI NIH HHS
Grant: P30 CA046592
NCI NIH HHS
Grant: R01 CA211016
NCI NIH HHS
Grant: R01 CA156685
NCI NIH HHS
Grant: R01 CA190176
NCI NIH HHS
Grant: R01 CA217510
NCI NIH HHS
Grant: R01 CA123088
NCI NIH HHS
Grant: R01 CA171306
MeSH Terms
Keywords